CD4 and small cell lung carcinoma: Our finding of increased effector memory CD4 T cells in high-risk patients, coupled with elevated CD56dim natural killer cells in low-risk patients, further suggests that metabolic reprogramming may influence both adaptive and innate immune responses in SCLC.